Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|November 21, 2007
Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomasIna Israel, Wolfgang Brandau, Georgios Farmakis, et al.
European Journal of Case Reports in Internal Medicine|March 8, 2024
Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?Georgios Pilianidis, Georgia Papanastasiou, Pinelopi Tikoudi, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 8, 2014
Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factorsIoannis Iakovou, Argyrios Doumas, Kosmas Badiavas, et al.
The Open Neurology Journal|November 20, 2008
Cerebral and Extracranial Neurodegeneration are Strongly Coupled in Parkinson's DiseaseJörg Spiegel, Dirk Hellwig, Wolfgang H Jost, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2007
Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's diseaseJörg Spiegel, Dirk Hellwig, Georgios Farmakis, et al.
Parkinsonism & Related Disorders|March 23, 2011
Myocardial MIBG scintigraphy may predict the course of motor symptoms in Parkinson's diseaseJulia Dorschner, Georgios Farmakis, Stefanie Behnke, et al.
Parkinsonism & Related Disorders|July 25, 2013
Evaluation of transcranial sonographic findings and MIBG cardiac scintigraphy in the diagnosis of idiopathic Parkinson's diseaseStefanie Behnke, Dirk Hellwig, Jan Bürmann, et al.
European Neurology|March 18, 2011
FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson's diseaseMagdalena Hubbuch, Georgios Farmakis, Andrea Schaefer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2010
Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of gliomaDirk Hellwig, Ralf Ketter, Bernd F M Romeike, et al.
Pageof 1